Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Short-term Investments (2016 - 2024)

AtriCure (ATRC) has disclosed Short-term Investments for 15 consecutive years, with $8.0 million as the latest value for Q2 2024.

  • On a quarterly basis, Short-term Investments fell 86.64% to $8.0 million in Q2 2024 year-over-year; TTM through Jun 2024 was $8.0 million, a 86.64% decrease, with the full-year FY2023 number at $53.0 million, down 15.93% from a year prior.
  • Short-term Investments was $8.0 million for Q2 2024 at AtriCure, down from $41.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $202.3 million in Q4 2020 to a low of $8.0 million in Q2 2024.
  • A 5-year average of $85.5 million and a median of $68.9 million in 2022 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: soared 328.91% in 2020, then tumbled 86.64% in 2024.
  • AtriCure's Short-term Investments stood at $202.3 million in 2020, then tumbled by 62.71% to $75.4 million in 2021, then dropped by 16.47% to $63.0 million in 2022, then decreased by 15.93% to $53.0 million in 2023, then tumbled by 84.93% to $8.0 million in 2024.
  • Per Business Quant, the three most recent readings for ATRC's Short-term Investments are $8.0 million (Q2 2024), $41.0 million (Q1 2024), and $53.0 million (Q4 2023).